GB9827430D0 - Differential expression in primary breast cancer - Google Patents
Differential expression in primary breast cancerInfo
- Publication number
- GB9827430D0 GB9827430D0 GBGB9827430.1A GB9827430A GB9827430D0 GB 9827430 D0 GB9827430 D0 GB 9827430D0 GB 9827430 A GB9827430 A GB 9827430A GB 9827430 D0 GB9827430 D0 GB 9827430D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- breast cancer
- differential expression
- primary breast
- primary
- differential
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57415—Specifically defined cancers of breast
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Hospice & Palliative Care (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9827430.1A GB9827430D0 (en) | 1998-12-11 | 1998-12-11 | Differential expression in primary breast cancer |
EP99959579A EP1137944A2 (en) | 1998-12-11 | 1999-12-10 | Differential expression in primary breast cancer |
PCT/GB1999/004183 WO2000036420A2 (en) | 1998-12-11 | 1999-12-10 | Differential expression in primary breast cancer |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9827430.1A GB9827430D0 (en) | 1998-12-11 | 1998-12-11 | Differential expression in primary breast cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
GB9827430D0 true GB9827430D0 (en) | 1999-02-03 |
Family
ID=10844141
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB9827430.1A Ceased GB9827430D0 (en) | 1998-12-11 | 1998-12-11 | Differential expression in primary breast cancer |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1137944A2 (en) |
GB (1) | GB9827430D0 (en) |
WO (1) | WO2000036420A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008044957A1 (en) * | 2006-10-09 | 2008-04-17 | Institut Molekulyarnoi Genetiki Rossiiskoi Akademii Nauk (Img Ran) | Proteom differential analysis method |
EP3555627B1 (en) | 2016-12-14 | 2023-11-22 | Purdue Research Foundation | Fibroblast activation protein (fap)-targeted imaging and therapy |
CN107988160A (en) * | 2018-01-11 | 2018-05-04 | 武汉大学深圳研究院 | Human breast cancer cell and its primary it is separately cultured and secondary culture method and purposes |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993005804A1 (en) * | 1991-09-18 | 1993-04-01 | Sloan-Kettering Institute For Cancer Research | Activated stromal fibroblast-specific antibody, f19 and methods of using the same |
DE4228389C2 (en) * | 1992-08-26 | 1994-07-21 | Kuebler Gmbh Dr | Collection and cultivation of transformed cells |
US5543297A (en) * | 1992-12-22 | 1996-08-06 | Merck Frosst Canada, Inc. | Human cyclooxygenase-2 cDNA and assays for evaluating cyclooxygenase-2 activity |
CA2160719A1 (en) * | 1993-04-26 | 1994-10-11 | Wade E. Bolton | Method of analyzing tumor cell dna content through tumor cell enrichment |
EP0904277A4 (en) * | 1996-02-16 | 2003-01-22 | Millennium Pharm Inc | Compositions and methods for the treatment and diagnosis of cardiovascular disease |
AU2452197A (en) * | 1996-04-10 | 1997-10-29 | California Pacific Medical Center | Genes amplified in cancer cells |
JP2001509664A (en) * | 1997-02-03 | 2001-07-24 | ヒューマン ジノーム サイエンシーズ,インコーポレイテッド | Breast cancer specific gene 1 |
GB9722320D0 (en) * | 1997-10-22 | 1997-12-17 | Janssen Pharmaceutica Nv | Human cell cycle checkpoint proteins |
-
1998
- 1998-12-11 GB GBGB9827430.1A patent/GB9827430D0/en not_active Ceased
-
1999
- 1999-12-10 WO PCT/GB1999/004183 patent/WO2000036420A2/en not_active Application Discontinuation
- 1999-12-10 EP EP99959579A patent/EP1137944A2/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO2000036420A3 (en) | 2000-10-19 |
WO2000036420A2 (en) | 2000-06-22 |
EP1137944A2 (en) | 2001-10-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002212527A1 (en) | Thermometry-based breast cancer risk assessment | |
HUP0104857A3 (en) | New cancer treatments | |
IL122026A0 (en) | Improvements in or relating to the prophylaxis of breast cancer | |
AU2890199A (en) | Gata-3-expression in human breast carcinoma | |
AU2948199A (en) | Breast cancer antigen | |
IL136167A0 (en) | Conjugates useful in the treatment of prostate cancer | |
AU2001288921A1 (en) | Human breast cancer biomarkers | |
GB9827430D0 (en) | Differential expression in primary breast cancer | |
GB2357434B (en) | Breast shield | |
AU2342299A (en) | Compositions and methods for detecting and treating breast cancer | |
GB9803447D0 (en) | Cancer diagnosis | |
IL145048A0 (en) | Casb619 involved in colon cancers | |
GB9613629D0 (en) | Reg gene expression in cancer tissue | |
GB9804361D0 (en) | Cancer treatment | |
GB9827102D0 (en) | New cancer treatments | |
GB9903035D0 (en) | Treating cancer | |
IL151662A0 (en) | Atm mutations in breast cancer | |
GB9804050D0 (en) | Cancer | |
GB2334579B (en) | Treating cancer | |
AU2001238697A1 (en) | Personal breast cancer indicator | |
GB9802420D0 (en) | Skin cancer alleviator | |
TW404173U (en) | Improving type brassiere | |
GB9812316D0 (en) | Cancer vaccines | |
GB9818023D0 (en) | Cancer treatment | |
GB9820000D0 (en) | Cancer treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |